https://india-pharma.gsk.com/en-in/ 2026-03-30T09:11:37.343Z https://india-pharma.gsk.com/en-in/company/ 2026-02-18T09:47:44.827Z https://india-pharma.gsk.com/en-in/company/purpose-strategy-and-culture/ 2026-04-02T05:32:48.287Z https://india-pharma.gsk.com/en-in/company/gsk-at-a-glance/ 2026-04-02T13:37:33.753Z https://india-pharma.gsk.com/en-in/company/discover-gsk-in-india/ 2025-07-15T12:57:33.323Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/ 2026-04-01T11:46:32.377Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/rskarnad/ 2025-07-15T12:57:55.07Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/subesh-williams/ 2025-07-15T12:57:53.797Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/dr-sunita-maheshwari/ 2025-07-15T12:57:53.113Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/manu-anand/ 2025-07-15T12:57:51.01Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/bhushan-akshikar/ 2025-07-15T12:57:50.4Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/mr-somasundaram-palamadairamaswamy/ 2025-07-15T12:57:48.973Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/mr-anup-wadhawan/ 2025-07-15T12:57:48.083Z https://india-pharma.gsk.com/en-in/company/board-of-directors-and-india-leadership-team/ronojit-biswas/ 2026-04-01T11:43:58.177Z https://india-pharma.gsk.com/en-in/company/policy-positions/ 2025-07-15T12:38:58.537Z https://india-pharma.gsk.com/en-in/company/welcome-to-gsk-s-century-of-trust-gallery/ 2026-03-18T07:43:59.72Z https://india-pharma.gsk.com/en-in/products/ 2026-03-09T06:45:50.727Z https://india-pharma.gsk.com/en-in/products/prescribing-information/ 2025-07-15T12:56:44.37Z https://india-pharma.gsk.com/en-in/products/prescribing-information-tab/ 2026-01-21T06:58:56.667Z https://india-pharma.gsk.com/en-in/products/healthcare/ 2025-07-21T16:40:19.667Z https://india-pharma.gsk.com/en-in/products/terms-and-conditions/ 2025-07-15T12:56:42.493Z https://india-pharma.gsk.com/en-in/products/regulator/ 2025-07-21T16:29:01.75Z https://india-pharma.gsk.com/en-in/products/report-a-possible-side-effect/ 2025-07-15T12:56:39.76Z https://india-pharma.gsk.com/en-in/careers/ 2026-02-24T11:38:59.39Z https://india-pharma.gsk.com/en-in/careers/lifeatgsk/ 2026-03-10T05:23:29.553Z https://india-pharma.gsk.com/en-in/careers/experienced-professionals/ 2025-07-15T12:55:37.33Z https://india-pharma.gsk.com/en-in/careers/early-careers-at-gsk-india/ 2026-03-18T09:10:40.867Z https://india-pharma.gsk.com/en-in/careers/how-we-hire/ 2025-07-15T12:55:30.777Z https://india-pharma.gsk.com/en-in/careers/how-we-hire/frequently-asked-questions/ 2025-07-15T12:55:34.77Z https://india-pharma.gsk.com/en-in/careers/how-we-hire/fraudulent-internet-recruitment-activities/ 2025-07-15T12:55:35.77Z https://india-pharma.gsk.com/en-in/investors/ 2026-03-18T09:25:47.22Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/ 2026-02-18T07:40:40.103Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/policies/ 2025-11-18T10:11:13.39Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/notices/ 2026-03-31T12:20:23.24Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/ 2026-03-07T12:58:00.61Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/events-calendar/ 2025-08-12T13:55:39.477Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/shareholding-pattern/ 2026-02-18T09:04:10.93Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/code-of-internal-procedures-and-conduct-for-regulating-monitoring-and-reporting-of-trading-by-insiders/ 2025-07-25T12:23:18.533Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/memorandum-and-articles-of-association/ 2025-07-25T12:23:21.8Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/newspaper-publication/ 2026-03-12T05:18:19.457Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/annual-return/ 2025-07-25T12:23:29.047Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/investors-grievances/ 2025-10-15T12:22:50.02Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/unpaid-unclaimed-dividend/ 2025-10-24T16:09:26.49Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/corporate-governance-report/ 2026-02-18T08:03:30.837Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/sebi-lodr-regulations/ 2026-01-20T06:15:03.473Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/download-forms/ 2025-07-25T12:23:41.36Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/annual-compliance-report/ 2026-02-18T07:36:42.607Z https://india-pharma.gsk.com/en-in/investors/shareholder-information/related-party-transactions/ 2026-02-18T07:34:12.87Z https://india-pharma.gsk.com/en-in/investors/annual-reports/ 2025-07-25T16:10:30.663Z https://india-pharma.gsk.com/en-in/investors/quarterly-results/ 2026-02-09T11:00:54.027Z https://india-pharma.gsk.com/en-in/investors/analyst-meets/ 2026-02-11T09:45:44.483Z https://india-pharma.gsk.com/en-in/media/ 2026-02-26T06:13:42.12Z https://india-pharma.gsk.com/en-in/media/press-releases/ 2026-03-18T09:19:48.2Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-june-30-2022/ 2025-07-15T12:56:20.32Z https://india-pharma.gsk.com/en-in/media/press-releases/media-release-q1-of-2022-23/ 2025-07-15T12:56:19.7Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-full-year-ended-march-31-2022/ 2025-07-15T12:56:19Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-launches-once-daily-single-inhaler-triple-therapy-for-copd-patients-for-the-first-time-in-india/ 2025-07-15T12:56:18.43Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-and-ms-dhoni-team-up-for-6-in-1-vaccination-awareness-campaign/ 2025-07-15T12:56:14.417Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-september-30-2021/ 2025-07-15T12:56:13.777Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-june-30-2021/ 2025-07-15T12:56:13.2Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-and-full-year-ended-march-31-2021/ 2025-07-15T12:56:12.637Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-ended-december-31-2020/ 2025-07-15T12:56:12.093Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-path-and-bharat-biotech-sign-product-transfer-agreement-to-help-ensure-long-term-supply-of-ground-breaking-malaria-vaccine/ 2025-07-15T12:56:11.437Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-ended-september-30-2020/ 2025-07-15T12:56:10.837Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-ended-june-30-2020/ 2025-07-15T12:56:08.743Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-announces-intention-to-produce-1-billion-doses-of-pandemic-vaccine-adjuvant-in-2021-to-support-multiple-covid-19-vaccine-collaborations/ 2025-07-15T12:56:08.183Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithklinepharmaceuticalslimitedannounces-results-for-the-quarter-and-full-year-ended-march-31-2020/ 2025-07-15T12:56:07.55Z https://india-pharma.gsk.com/en-in/media/press-releases/appointments-to-the-glaxosmithkline-pharmaceuticals-ltd-board/ 2025-07-15T12:56:06.843Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-delivers-strong-financials-led-by-pharma-growth/ 2025-07-15T12:56:06.173Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-announces-results-for-the-quarter-ended-september-30-2022/ 2025-07-15T12:56:05.567Z https://india-pharma.gsk.com/en-in/media/press-releases/new-data-show-shingrix-can-provide-at-least-10-years-of-protection-against-shingles-in-adults-aged-50-years-and-over/ 2025-07-15T12:56:03.063Z https://india-pharma.gsk.com/en-in/media/press-releases/continued-momentum-across-general-medicines-and-specialty/ 2025-07-15T12:56:02.413Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-launches-shingrix-in-india-a-vaccine-for-the-prevention-of-shingles-in-adults-aged-50-years-and-above/ 2025-07-15T12:56:01.707Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-reported-improved-profitability-with-continued-momentum-across-general-medicines-and-specialty-declares-annual-dividend-of-rs-32/ 2025-07-15T12:56:01.15Z https://india-pharma.gsk.com/en-in/media/press-releases/amitabh-bachchan-partners-with-gsk-for-shingles-awareness-and-prevention/ 2025-07-15T12:55:59.713Z https://india-pharma.gsk.com/en-in/media/press-releases/general-medicines-delivers-4-revenue-growth-despite-nlem-impact-along-with-a-sequential-recovery-in-the-vaccines-business/ 2025-07-15T12:55:56.25Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-registers-5-growth/ 2025-07-15T12:55:55.64Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-gsk-announces-its-financial-results-for-the-third-quarter-ended-31st-december-2023/ 2025-07-15T12:55:55.02Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceutical-limited-reports-strong-double-digit-growth-and-improved-profitability-for-the-quarter/ 2025-07-15T12:55:54.473Z https://india-pharma.gsk.com/en-in/media/press-releases/gsks-new-campaign-asks-parents-to-support-their-childrens-future-with-7-crucial-vaccinations/ 2025-07-15T12:55:53.863Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-reports-continued-growth-and-profitability-for-the-quarter/ 2025-07-15T12:55:52.95Z https://india-pharma.gsk.com/en-in/media/press-releases/yeh-science-hai-amitabh-bachchan-and-manoj-pahwa-partner-with-gsk-for-new-shingles-awareness-and-prevention-campaign/ 2025-07-21T17:01:08.87Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-crosses-rs1000-crore-in-revenue-from-operations/ 2025-07-15T12:55:48.743Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-gsk-delivers-strong-q3-performance-with-double-digit-growth/ 2025-07-15T12:55:47.943Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-and-yuva-unstoppable-transform-education-with-100th-smart-classroom-in-nashik/ 2025-07-15T12:55:47.373Z https://india-pharma.gsk.com/en-in/media/press-releases/data-at-the-end-of-a-long-term-study-shows-shingrix-continues-to-provide-high-protection-against-shingles-in-adults-aged-50-and-over-for-more-than-a-decade/ 2025-07-15T12:55:46.533Z https://india-pharma.gsk.com/en-in/media/press-releases/most-people-over-50-in-india-unaware-of-shingles-disease-despite-being-at-risk1/ 2025-07-15T12:55:44.107Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-reports-topline-growth-and-profitability-for-full-year-ended-31-march-2025/ 2025-07-15T12:55:43.58Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-delivers-sustained-profitability-for-quarter-ended-june-30-2025-continues-to-invest-in-key-portfolios/ 2025-08-05T12:43:04.923Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-forays-into-oncology-in-india-with-jemperli-and-zejula-bringing-precision-therapies-for-gynaecological-cancers/ 2025-08-25T18:10:26.503Z https://india-pharma.gsk.com/en-in/media/press-releases/gsk-s-nashik-facility-achieves-global-bsi-amr-kitemark-certification/ 2025-10-13T02:58:35.31Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-delivers-competitive-performance-in-q2fy26-ebidta-margin-grows-by-250-basis-points/ 2025-11-06T11:10:04.183Z https://india-pharma.gsk.com/en-in/media/press-releases/glaxosmithkline-pharmaceuticals-limited-crosses-inr-1-000-crores-in-topline-plus81-as-key-portfolios-deliver/ 2026-02-09T10:32:07.927Z https://india-pharma.gsk.com/en-in/media/press-releases/shingles-disrupts-life-yet-half-of-ageing-indians-with-chronic-conditions-don-t-talk-about-prevention-with-their-doctors1/ 2026-02-26T07:57:03.43Z https://india-pharma.gsk.com/en-in/media/media-contacts/ 2025-07-15T12:56:30.65Z https://india-pharma.gsk.com/en-in/media/in-focus/ 2026-03-18T09:17:19.673Z https://india-pharma.gsk.com/en-in/media/in-focus/corporate/ 2026-01-05T10:11:58.507Z https://india-pharma.gsk.com/en-in/media/in-focus/csr/ 2025-07-15T12:56:25.433Z https://india-pharma.gsk.com/en-in/media/in-focus/disease-awareness/ 2026-01-05T11:19:29.287Z https://india-pharma.gsk.com/en-in/media/our-social-media/ 2025-07-15T12:56:31.71Z https://india-pharma.gsk.com/en-in/responsibility/ 2026-04-02T05:37:02.57Z https://india-pharma.gsk.com/en-in/responsibility/inclusion/ 2026-01-28T05:53:42.81Z https://india-pharma.gsk.com/en-in/responsibility/ethical-standards/ 2026-03-18T09:57:09.727Z https://india-pharma.gsk.com/en-in/responsibility/ethical-standards/engaging-with-healthcare-professionals/ 2025-07-15T12:57:22.647Z https://india-pharma.gsk.com/en-in/responsibility/ethical-standards/engaging-with-healthcare-professionals/tov-disclosure-report-gsk-india/ 2025-07-15T12:57:25.53Z https://india-pharma.gsk.com/en-in/responsibility/corporate-social-responsibility/ 2025-10-09T06:45:45.397Z https://india-pharma.gsk.com/en-in/responsibility/environment-health-safety/ 2026-03-12T09:01:01.47Z https://india-pharma.gsk.com/en-in/terms-of-use/ 2025-07-15T12:57:15.197Z https://india-pharma.gsk.com/en-in/legal-disclaimer/ 2025-07-15T12:57:14.527Z https://india-pharma.gsk.com/en-in/cookie-policy/ 2025-07-15T12:57:13.173Z https://india-pharma.gsk.com/en-in/accessibility/ 2025-07-15T12:57:12.623Z https://india-pharma.gsk.com/en-in/search/ 2025-07-15T12:55:41.383Z https://india-pharma.gsk.com/en-in/error-404/ 2025-07-15T12:55:41.76Z https://india-pharma.gsk.com/en-in/sitemap/ 2025-07-22T14:55:56.24Z https://india-pharma.gsk.com/en-in/contact-us/ 2025-07-15T12:55:28.52Z https://india-pharma.gsk.com/en-in/innovation/ 2026-03-25T06:23:41.013Z https://india-pharma.gsk.com/en-in/innovation/therapeutic-areas/ 2026-03-25T06:32:26.117Z https://india-pharma.gsk.com/en-in/innovation/trials/ 2025-07-15T12:55:22.743Z https://india-pharma.gsk.com/en-in/innovation/trials/provision-of-unlicensed-medicines-for-unmet-medical-needs/ 2025-07-22T11:14:15.533Z https://india-pharma.gsk.com/en-in/innovation/trials/data-transparency/ 2025-07-15T12:55:25.227Z https://india-pharma.gsk.com/en-in/innovation/trials/diversity-in-clinical-trials/ 2025-07-15T12:55:23.537Z https://india-pharma.gsk.com/en-in/locations/ 2025-07-15T12:17:13.753Z https://india-pharma.gsk.com/en-in/digital-sustainability/ 2026-03-30T06:40:38.647Z